Centered to Become 
a Top Five Hub for 
Health Innovation
CBSA Board of Directors Prioritizes Strategic Growth
CBSA’s Board of Directors plays a central role in advancing 
Colorado’s drive to become a top-five U.S. hub for life sciences. 
The board is leading development of the Colorado Life Sciences 
Strategic Roadmap, a data-driven initiative that will identify 
high-value growth opportunities and investment priorities to 
strengthen Colorado’s competitiveness and guide the ecosystem’s 
next phase of growth.
These leaders include C-suite executives of publicly traded 
companies, serial entrepreneurs who transform ideas into therapies, 
distinguished scientists and academic leaders, and experts in 
finance, law, real estate, and operations. Together, they help ensure 
Colorado has the infrastructure, talent, capital, and collaborative 
environment needed to accelerate innovation and growth.
Board of Directors 
Executive Committee

Byron Hewett
Life Sciences Strategic Advisor
BOARD CHAIR
Robin Harper Cowie
Chief Financial Officer
Biodesix
BOARD VICE CHAIR
Rachelle Moulton
Assurance Partner
EY
BOARD TREASURER
FINANCE & AUDIT COMMITTEE CHAIR
Rita Sanzgiri, Ph.D., J.D.
Intellectual Property Attorney,
Biotech, Pharmaceuticals, and 
Life Sciences
BOARD SECRETARY
COMMUNITY GROWTH & 
ENGAGEMENT COMMITTEE CHAIR
Ethan Mann, Ph.D., M.B.A.
Life Sciences Executive
PAST BOARD CHAIR
Jennifer Chavez
Senior Director, Leasing
BioMed Realty
DEVELOPMENT COMMITTEE CHAIR
April Giles
Executive Director
End Drug Shortages Alliance
STRATEGIC PLANNING COMMITTEE 
CHAIR
Ryan Crisman, Ph.D.
Cofounder and Chief 
Technology Officer
Umoja Biopharma
NOMINATING COMMITTEE CHAIR
Dan Wittenberg, J.D.
Partner
Snell & Wilmer LLP
GOVERNANCE COMMITTEE CHAIR
2026-27 BIOSCIENCE COLORADO     49

View this content as a flipbook by clicking here.